Moreover, co-inhibiting QPRT and NAMPT (e.g., with FK866) synergistically blocks NAD+ synthesis, inducing lethal energy depletion in tumor cells and enhancing therapeutic efficacy (Kudo et al., 2024). This evidence concerns the gene QPRT and neoplasm.